Covered recipient · General Payments record
MARIE WATSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,030.14
- Reported across 203 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $774.35 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $237.13 | 10 |
| Amgen Inc. | $141.82 | 9 |
| Silk Road Medical, Inc. | $108.69 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $76.62 | 4 |
| ABBVIE INC. | $58.96 | 3 |
| PFIZER INC. | $31.91 | 2 |
| Merck Sharp & Dohme Corporation | $27.21 | 1 |
| DEXCOM, INC. | $22.72 | 1 |
| Astellas Pharma US Inc | $22.19 | 1 |
| Abbott Laboratories | $18.55 | 1 |
| TOLMAR, INC. | $15.14 | 1 |
| Novo Nordisk AS | $13.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.55 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125358173 | CMS |
| ABBVIE INC. | $18.19 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108384631 | CMS |
| ABBVIE INC. | $20.74 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108384633 | CMS |
| ABBVIE INC. | $20.03 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108384635 | CMS |
| Amgen Inc. | $14.53 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714440 | CMS |
| Amgen Inc. | $13.71 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411390 | CMS |
| Amgen Inc. | $16.83 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411392 | CMS |
| Amgen Inc. | $16.85 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411394 | CMS |
| Amgen Inc. | $16.51 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714442 | CMS |
| Amgen Inc. | $20.79 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411396 | CMS |
| Amgen Inc. | $12.83 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714444 | CMS |
| Amgen Inc. | $14.60 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714446 | CMS |
| Amgen Inc. | $15.17 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411398 | CMS |
| Astellas Pharma US Inc | $22.19 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139527626 | CMS |
| Dexcom, Inc. | $22.72 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153376832 | CMS |
| Lilly USA, LLC | $21.18 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135807179 | CMS |
| Lilly USA, LLC | $24.45 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135755441 | CMS |
| Lilly USA, LLC | $9.24 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135812627 | CMS |
| Lilly USA, LLC | $20.93 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135835863 | CMS |
| Lilly USA, LLC | $6.17 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135812625 | CMS |
| Lilly USA, LLC | $18.97 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135807181 | CMS |
| Lilly USA, LLC | $94.06 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135811769 | CMS |
| Lilly USA, LLC | $21.23 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135776010 | CMS |
| Lilly USA, LLC | $8.78 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135835866 | CMS |
| Lilly USA, LLC | $12.12 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135755443 | CMS |
| Merck Sharp & Dohme LLC | $27.21 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141897396 | CMS |
| Novartis Pharmaceuticals Corporation | $20.68 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087371128 | CMS |
| Novartis Pharmaceuticals Corporation | $16.26 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087371118 | CMS |
| Novartis Pharmaceuticals Corporation | $19.77 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087371170 | CMS |
| Novartis Pharmaceuticals Corporation | $19.91 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087371174 | CMS |
| Novo Nordisk Inc | $13.41 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100273514 | CMS |
| PFIZER INC. | $14.03 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131171248 | CMS |
| PFIZER INC. | $17.88 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131673640 | CMS |
| Silk Road Medical, Inc. | $108.69 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082276438 | CMS |
| Tolmar, Inc. | $15.14 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138721008 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.